Recon: Biogen, between layoffs, announces $7.3B deal to acquire Reata; Quest launches consumer blood test for Alzheimer’s

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy